Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![WhatMarketMind Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1869290335937105920.png) WhatMarketMinds [@WhatMarketMind](/creator/twitter/WhatMarketMind) on x 1106 followers
Created: 2025-05-05 13:41:21 UTC


$GENS 20250424-DBS-Genting Singapore Ltd (GENS) 
$MLT 20250424-DBS-Mapletree Logistics Trust (MLT) Saving for a rainy day
$KEP 20250424-DBS-SG Keppel Ltd  (KEP)  Stronger_than_expected 1Q25  (KEP) 
$BBL 20250424-DBS-TH Bangkok Bank  (BBL)  Weathering near_term turbulence
$CZR 20250429-Deutsche Bank-Caesars Entertainment Corporation (CZR) Key Takeaways from Q1'25 Results
$AER 20250430-CITI-AerCap  (AER)  An Attractive Simplicity Focusing on Profitability and Shareholder Ret
$AIR 20250430-CITI-Airbus SE  (AIR)  Q1: 5% profit beat, but FCF outflow much smaller than expected
$ALB 20250430-CITI-Albemarle  (ALB)  1Q25 Beat on Input Costs & Productivity; FY25 Guidance Scenarios Un
$ALLFG 20250430-CITI-Allfunds  (ALLFG)  Model Update
$6770 20250430-CITI-Alps Alpine  (6770)  Q4 negative–need to assess impact of reciprocal tariffs
$ALSEA 20250430-CITI-Alsea  (ALSEA)  1Q25 Results & CC Highlights. Battling Soft Demand and Starbucks Spil
$AMGN 20250430-CITI-Amgen Inc.  (AMGN) 1Q25 Consensus as of Today
$ANTM 20250430-CITI-Aneka Tambang  (ANTM)  1Q25–A Strong Beat as Gold and Nickel Are All Firing; Result F
$AR 20250430-CITI-Antero Resources  (AR)  Neutral _ Strong Pricing Continues to Provide Confidence in C
$2454 20250430-J.P. Morgan-MediaTek Inc. (2454)  First Take: 1Q25 result in line, sluggish 2Q25 and conse
$688234 20250430-J.P. Morgan-SICC_A (688234) First Take: 1Q25 results a meaningful miss, reflecting product pr
$8035 20250430-J.P. Morgan-Tokyo El_ectron  (8035)  4Q results and guidance in line with expectations; no 
$AIBG 20250501-CITI-AIB Group PLC  (AIBG)  1Q25 trading update shows solid operating trends and strong cap
$AIBG 20250501-CITI-AIB Group PLC  (AIBG)  NII waterfall 2025_26E and sensitivities
$2802 20250501-CITI-Ajinomoto  (2802)  Implications from Q1 US hyperscaler results: AI investment still a 
$MLXS 20250501-J.P. Morgan-Melexis (MLXS)  Q1’25 review: Management indicating trough revenues and margin
$RIO 20250501-J.P. Morgan-Rio Tinto plc (RIO)  What next after dual listing structure is preserved? Top p
$9064 20250501-J.P. Morgan-Yamato Holdings  (9064) 4Q results: FY2025 guidance lower than consensus view, 
$AF 20250502-Bernstein-Air France_KLM (AF) Air France_KLM : Toujours une hausse des co?ts hors carburan
$ABNB 20250502-Bernstein-Airbnb Inc (ABNB) Airbnb 1Q25: Nearing the end of the rainbow
$BIIB 20250502-Bernstein-Biogen Inc (BIIB) Biogen 1Q25: Strong Q1 print, but the headline numbers mask US
$CI 20250502-Bernstein-Cigna Group (CI) Quick Take: CI 1Q25_Solid beat on better than expected  Healthc
$ETN 20250502-Bernstein-Eaton Corp PLC (ETN) Quick Take: ETN 1Q25_solid beat; focus on ordersbacklog
$H 20250502-Bernstein-Hyatt Hotels Corp (H) Hyatt 1Q25: How great is this Rev_Party?
$ETNB 20250502-Goldman Sachs-89bio Inc.  (ETNB) : 1Q EPS; Ph3 ENLIGHTEN NASH programs are progressing
$FOLD 20250502-Goldman Sachs-Amicus Therapeutics Inc.  (FOLD) : 1Q revenue miss; Monitoring PomOp commerc
$AJG 20250502-Goldman Sachs-Arthur J. Gallagher & Co.  (AJG) 1Q25 EPS Beat on Brokerage Margin & Corpora
$BIRG 20250502-Goldman Sachs-Bank of Ireland Group  (BIRG) : Q1’25 IMS
$DANSKE 20250502-Goldman Sachs-Danske Bank  (DANSKE) : Q1’25 First Look
$FND 20250502-Goldman Sachs-Floor & Decor Holdings  (FND) : Macro environment remains challenging; Manag
$2196 20250502-Goldman Sachs-Fosun Pharma  (2196) : Earnings Review: 1Q missed with deeper VBP impacts; p
$INGA 20250502-Goldman Sachs-ING Groep NV  (INGA) : Q1’25 First Look
$3064 20250502-Goldman Sachs-MonotaRO  (3064)  Earnings Review: Slightly above expectations on better_than
$NWG 20250502-Goldman Sachs-Natwest Group  (NWG) : Q1’25 First Look
$688249 20250502-Goldman Sachs-Nexchip  (688249) : 55nm  40nm 28nm in expansion; CIS to drive growth ahead; 1Q
$PSON 20250502-Goldman Sachs-Pearson  (PSON) : 1Q25 trading update broadly in line, 2025 outlook reiterate
$RBLX 20250502-Goldman Sachs-Roblox  (RBLX) : Q1’25 EPS_First Take
$SHEL 20250502-Goldman Sachs-Shell Plc  (SHEL) : Strong results, resilient cash flow and balance sheet. C
$WEIR 20250502-Goldman Sachs-Weir Group  (WEIR) : Model adjustments to reflect completion of Micromine acq
$ALNY 20250502-UBS-Alnylam Pharmaceuticals Inc (ALNY) 1Q ATTR_CM early launch color highlights robust tre
$FOLD 20250502-UBS-Amicus Therapeutics Inc (FOLD) 1Q25 results: PomOp '25 guide lowered but LT on_track, 
$ASND 20250502-UBS-Ascendis Pharma AS (ASND) Strong 1Q shows accelerating new starts for  Yorvipath
$AUTOA 20250502-UBS-Auto Trader Plc (AUTOA) AUTO Apr RPI: _despite the political and economic turbulence...
$BHVN 20250502-UBS-Biohaven Limited (BHVN) Regulatory pessimism overdone on SCA, representing attractive 
$BMRN 20250502-UBS-BioMarin Pharmaceutical Inc (BMRN) 1Q25: minimal surprises, potential inflection in gr

![](https://pbs.twimg.com/card_img/1918184808200671232/i6v2xE-s?format=jpg&name=800x419)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1919386938186068114/c:line.svg)

**Related Topics**
[coins entertainment](/topic/coins-entertainment)
[$czr](/topic/$czr)
[bangkok](/topic/bangkok)
[saving](/topic/saving)
[$mlt](/topic/$mlt)
[singapore](/topic/singapore)
[$gens](/topic/$gens)
[coins defi](/topic/coins-defi)

[Post Link](https://x.com/WhatMarketMind/status/1919386938186068114)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

WhatMarketMind Avatar WhatMarketMinds @WhatMarketMind on x 1106 followers Created: 2025-05-05 13:41:21 UTC

$GENS 20250424-DBS-Genting Singapore Ltd (GENS) $MLT 20250424-DBS-Mapletree Logistics Trust (MLT) Saving for a rainy day $KEP 20250424-DBS-SG Keppel Ltd (KEP) Stronger_than_expected 1Q25 (KEP) $BBL 20250424-DBS-TH Bangkok Bank (BBL) Weathering near_term turbulence $CZR 20250429-Deutsche Bank-Caesars Entertainment Corporation (CZR) Key Takeaways from Q1'25 Results $AER 20250430-CITI-AerCap (AER) An Attractive Simplicity Focusing on Profitability and Shareholder Ret $AIR 20250430-CITI-Airbus SE (AIR) Q1: 5% profit beat, but FCF outflow much smaller than expected $ALB 20250430-CITI-Albemarle (ALB) 1Q25 Beat on Input Costs & Productivity; FY25 Guidance Scenarios Un $ALLFG 20250430-CITI-Allfunds (ALLFG) Model Update $6770 20250430-CITI-Alps Alpine (6770) Q4 negative–need to assess impact of reciprocal tariffs $ALSEA 20250430-CITI-Alsea (ALSEA) 1Q25 Results & CC Highlights. Battling Soft Demand and Starbucks Spil $AMGN 20250430-CITI-Amgen Inc. (AMGN) 1Q25 Consensus as of Today $ANTM 20250430-CITI-Aneka Tambang (ANTM) 1Q25–A Strong Beat as Gold and Nickel Are All Firing; Result F $AR 20250430-CITI-Antero Resources (AR) Neutral _ Strong Pricing Continues to Provide Confidence in C $2454 20250430-J.P. Morgan-MediaTek Inc. (2454) First Take: 1Q25 result in line, sluggish 2Q25 and conse $688234 20250430-J.P. Morgan-SICC_A (688234) First Take: 1Q25 results a meaningful miss, reflecting product pr $8035 20250430-J.P. Morgan-Tokyo El_ectron (8035) 4Q results and guidance in line with expectations; no $AIBG 20250501-CITI-AIB Group PLC (AIBG) 1Q25 trading update shows solid operating trends and strong cap $AIBG 20250501-CITI-AIB Group PLC (AIBG) NII waterfall 2025_26E and sensitivities $2802 20250501-CITI-Ajinomoto (2802) Implications from Q1 US hyperscaler results: AI investment still a $MLXS 20250501-J.P. Morgan-Melexis (MLXS) Q1’25 review: Management indicating trough revenues and margin $RIO 20250501-J.P. Morgan-Rio Tinto plc (RIO) What next after dual listing structure is preserved? Top p $9064 20250501-J.P. Morgan-Yamato Holdings (9064) 4Q results: FY2025 guidance lower than consensus view, $AF 20250502-Bernstein-Air France_KLM (AF) Air France_KLM : Toujours une hausse des co?ts hors carburan $ABNB 20250502-Bernstein-Airbnb Inc (ABNB) Airbnb 1Q25: Nearing the end of the rainbow $BIIB 20250502-Bernstein-Biogen Inc (BIIB) Biogen 1Q25: Strong Q1 print, but the headline numbers mask US $CI 20250502-Bernstein-Cigna Group (CI) Quick Take: CI 1Q25_Solid beat on better than expected Healthc $ETN 20250502-Bernstein-Eaton Corp PLC (ETN) Quick Take: ETN 1Q25_solid beat; focus on ordersbacklog $H 20250502-Bernstein-Hyatt Hotels Corp (H) Hyatt 1Q25: How great is this Rev_Party? $ETNB 20250502-Goldman Sachs-89bio Inc. (ETNB) : 1Q EPS; Ph3 ENLIGHTEN NASH programs are progressing $FOLD 20250502-Goldman Sachs-Amicus Therapeutics Inc. (FOLD) : 1Q revenue miss; Monitoring PomOp commerc $AJG 20250502-Goldman Sachs-Arthur J. Gallagher & Co. (AJG) 1Q25 EPS Beat on Brokerage Margin & Corpora $BIRG 20250502-Goldman Sachs-Bank of Ireland Group (BIRG) : Q1’25 IMS $DANSKE 20250502-Goldman Sachs-Danske Bank (DANSKE) : Q1’25 First Look $FND 20250502-Goldman Sachs-Floor & Decor Holdings (FND) : Macro environment remains challenging; Manag $2196 20250502-Goldman Sachs-Fosun Pharma (2196) : Earnings Review: 1Q missed with deeper VBP impacts; p $INGA 20250502-Goldman Sachs-ING Groep NV (INGA) : Q1’25 First Look $3064 20250502-Goldman Sachs-MonotaRO (3064) Earnings Review: Slightly above expectations on better_than $NWG 20250502-Goldman Sachs-Natwest Group (NWG) : Q1’25 First Look $688249 20250502-Goldman Sachs-Nexchip (688249) : 55nm 40nm 28nm in expansion; CIS to drive growth ahead; 1Q $PSON 20250502-Goldman Sachs-Pearson (PSON) : 1Q25 trading update broadly in line, 2025 outlook reiterate $RBLX 20250502-Goldman Sachs-Roblox (RBLX) : Q1’25 EPS_First Take $SHEL 20250502-Goldman Sachs-Shell Plc (SHEL) : Strong results, resilient cash flow and balance sheet. C $WEIR 20250502-Goldman Sachs-Weir Group (WEIR) : Model adjustments to reflect completion of Micromine acq $ALNY 20250502-UBS-Alnylam Pharmaceuticals Inc (ALNY) 1Q ATTR_CM early launch color highlights robust tre $FOLD 20250502-UBS-Amicus Therapeutics Inc (FOLD) 1Q25 results: PomOp '25 guide lowered but LT on_track, $ASND 20250502-UBS-Ascendis Pharma AS (ASND) Strong 1Q shows accelerating new starts for Yorvipath $AUTOA 20250502-UBS-Auto Trader Plc (AUTOA) AUTO Apr RPI: _despite the political and economic turbulence... $BHVN 20250502-UBS-Biohaven Limited (BHVN) Regulatory pessimism overdone on SCA, representing attractive $BMRN 20250502-UBS-BioMarin Pharmaceutical Inc (BMRN) 1Q25: minimal surprises, potential inflection in gr

XX engagements

Engagements Line Chart

Related Topics coins entertainment $czr bangkok saving $mlt singapore $gens coins defi

Post Link

post/tweet::1919386938186068114
/post/tweet::1919386938186068114